Lecanemab (Drug)

September 27, 2022

Alzheimer’s drug slows cognitive decline in key study

[ad_1] Biogen and Eisai reported the results of a large, late-stage clinical trial of lecanemab, a drug they are developing. [ad_2] Source link
Alzheimer’s drug slows cognitive decline in key study
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more